These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 28212963)
1. Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force. Powers JH; Patrick DL; Walton MK; Marquis P; Cano S; Hobart J; Isaac M; Vamvakas S; Slagle A; Molsen E; Burke LB Value Health; 2017 Jan; 20(1):2-14. PubMed ID: 28212963 [TBL] [Abstract][Full Text] [Related]
2. Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force. Walton MK; Powers JH; Hobart J; Patrick D; Marquis P; Vamvakas S; Isaac M; Molsen E; Cano S; Burke LB; Value Health; 2015 Sep; 18(6):741-52. PubMed ID: 26409600 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report. Malone DC; Ramsey SD; Patrick DL; Johnson FR; Mullins CD; Roberts MS; Willke RJ; Marshall DA Value Health; 2020 Apr; 23(4):409-415. PubMed ID: 32327155 [TBL] [Abstract][Full Text] [Related]
5. Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force. Edgar CJ; Bush EN; Adams HR; Ballinger R; Byrom B; Campbell M; Eremenco S; McDougall F; Papadopoulos E; Slagle AF; Coons SJ Value Health; 2023 Jul; 26(7):959-967. PubMed ID: 37385712 [TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
7. A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials. Burton BK; Skalicky A; Baerwald C; Bilder DA; Harding CO; Ilan AB; Jurecki E; Longo N; Madden DT; Sivri HS; Wilcox G; Thomas J; Delaney K Mol Genet Metab Rep; 2021 Dec; 29():100810. PubMed ID: 34815941 [TBL] [Abstract][Full Text] [Related]
8. Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report. Benjamin K; Vernon MK; Patrick DL; Perfetto E; Nestler-Parr S; Burke L Value Health; 2017; 20(7):838-855. PubMed ID: 28712612 [TBL] [Abstract][Full Text] [Related]
9. Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. Wailoo AJ; Hernandez-Alava M; Manca A; Mejia A; Ray J; Crawford B; Botteman M; Busschbach J Value Health; 2017 Jan; 20(1):18-27. PubMed ID: 28212961 [TBL] [Abstract][Full Text] [Related]
10. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E; Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250 [TBL] [Abstract][Full Text] [Related]
11. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. Rothman M; Burke L; Erickson P; Leidy NK; Patrick DL; Petrie CD Value Health; 2009; 12(8):1075-83. PubMed ID: 19804437 [TBL] [Abstract][Full Text] [Related]
12. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Patrick DL; Burke LB; Gwaltney CJ; Leidy NK; Martin ML; Molsen E; Ring L Value Health; 2011 Dec; 14(8):967-77. PubMed ID: 22152165 [TBL] [Abstract][Full Text] [Related]
13. Recommendations for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials. Romero H; DeBonis D; O'Donohoe P; Wyrwich KW; Arnera V; Platko JV; Willgoss T; Harris K; Crescioni M; Steele S; Eremenco S; Value Health; 2022 Jul; 25(7):1090-1098. PubMed ID: 35379564 [TBL] [Abstract][Full Text] [Related]
15. Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force. O'Donohoe P; Reasner DS; Kovacs SM; Byrom B; Eremenco S; Barsdorf AI; Arnera V; Coons SJ Value Health; 2023 May; 26(5):623-633. PubMed ID: 37121630 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal Modeling Approaches to Assess the Association Between Changes in 2 Clinical Outcome Assessments. Odom D; McLeod L; Sherif B; Nelson L; McSorley D Ther Innov Regul Sci; 2018 May; 52(3):306-312. PubMed ID: 29714541 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE. Askanase AD; Tang W; Zuraw Q; Gordon R; Brotherton B; Merrill JT Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37012059 [TBL] [Abstract][Full Text] [Related]
18. Correspondence Between Clinician Ratings of Vulvovaginal Health and Patient-Reported Sexual Function After Cancer. Flynn KE; Lin L; Carter J; Baser RE; Goldfarb S; Saban S; Weinfurt KP J Sex Med; 2021 Oct; 18(10):1768-1774. PubMed ID: 34446376 [TBL] [Abstract][Full Text] [Related]
19. Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS). Matza LS; Stewart KD; Phillips G; Delio P; Naismith RT Mult Scler Relat Disord; 2019 Oct; 35():253-261. PubMed ID: 31437740 [TBL] [Abstract][Full Text] [Related]
20. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]